Nicotinic agonist effects on BMI and neuronal response in overweight/obese adults
This research study plans to examine the effects of an investigational new drug on neuronal, physiological, and behavioral mechanisms of obesity in the general population.
This Study is
No Longer Enrolling
This study plans to learn more about the effects of an investigational new drug (DMXB-A) and its effects on obesity. The study drug has similar effects to nicotine. Since nicotine has been found to effect appetite, we are interested in studying the effects of the study drug, which has similarities to nicotine, on how your brain responds to such things as pictures of food. This study drug has not been approved by the Food and Drug Administration (FDA), and is considered experimental.
MoreAdult
BMI greater than 27; Be 21-65 years old; Have no known cardiovascular disease; Be a non-smoker; Not be pregnant or trying to conceive; Be able to complete an MRI scan.
Basic Science
Outpatient CTRC
University of Colorado Hospital
Protocol Number: 15-0650
More information available at ClinicalTrials.gov: NCT02458313
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers